DiaMedica Therapeutics (DMAC) Receivables - Net (2017 - 2026)
DiaMedica Therapeutics (DMAC) posted quarterly Receivables - Net of $301000.0 for Q1 2026, up 18.97% year-over-year from $253000.0 in Q1 2025, and up 16.67% quarter-over-quarter from $258000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Receivables - Net (2017 - 2026) Analysis & Trends
DiaMedica Therapeutics' Receivables - Net history runs 10 years deep, the most recent figure standing at $301000.0 for Q1 2026.
- In Q1 2026, Receivables - Net rose 18.97% year-over-year to $301000.0; the TTM figure through Mar 2026 stood at $301000.0 (up 18.97% YoY), while the FY2025 annual figure was $258000.0, up 9.32% from the prior year.
- Receivables - Net for Q1 2026 stood at $301000.0, up from $258000.0 in the prior quarter.
- The five-year high for Receivables - Net was $399000.0 in Q1 2024, with the low at $57000.0 in Q1 2023.
- The 5-year median for Receivables - Net is $253000.0 (2025), against an average of $228588.2.
- The sharpest annual moves came in 2023 and 2024: Receivables - Net sank 66.07% in 2023, then jumped 600.0% in 2024.
- DiaMedica Therapeutics' Receivables - Net stood at $82000.0 in 2022, then surged by 350.0% to $369000.0 in 2023, then tumbled by 36.04% to $236000.0 in 2024, then climbed by 9.32% to $258000.0 in 2025, then rose by 16.67% to $301000.0 in 2026.
- Business Quant data shows DMAC's Receivables - Net at $301000.0 in Q1 2026, $258000.0 in Q4 2025, and $260000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 244,000.00 |
| Jun 30, 2026 | 244,000.00 |
| Mar 31, 2026 | 301,000.00 |
| Mar 31, 2026 | 301,000.00 |
| Dec 31, 2025 | 258,000.00 |
| Dec 31, 2025 | 258,000.00 |
| Sep 30, 2025 | 260,000.00 |
| Sep 30, 2025 | 260,000.00 |
| Jun 30, 2025 | 161,000.00 |
| Jun 30, 2025 | 161,000.00 |
| Mar 31, 2025 | 253,000.00 |
| Mar 31, 2025 | 253,000.00 |
| Dec 31, 2024 | 236,000.00 |
| Dec 31, 2024 | 236,000.00 |
| Sep 30, 2024 | 290,000.00 |
| Sep 30, 2024 | 290,000.00 |
| Jun 30, 2024 | 391,000.00 |
| Jun 30, 2024 | 391,000.00 |
| Mar 31, 2024 | 399,000.00 |
| Mar 31, 2024 | 399,000.00 |